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Previews‘‘flips out’’ toward the antibody, resulting
in narrowing of the substrate-binding
cleft (Figure 1). The narrowing of the
substrate binding cleft between the V-B
loop and the region of the active site
involved in substrate binding, S1’, along
with likely imposed constrains on the
loop flexibility explain the basis of the
allosteric inhibition by the LEM-2/15
antibody.
Most impressive is the fact that the
antibody reduced cell surface collageno-
lytic activity in a fibrosarcoma cell line
having little effect on the enzyme dimer-
ization or on MT1-MMP-dependent acti-
vation of MMP-2. This work marks the
progress toward identification of the
enzyme specific surface exposed epi-
topes that are important for the control
of enzymatic activity and can provide
an entree into development of novel
therapeuticsREFERENCES
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In this issue of Structure, Glatt and colleagues report the structure of the Kti11/Kti13 heterodimer. This study
reveals how dimerization and Fe2+ binding are required for modification of both tRNA and EF2, thus suggest-
ing a mechanism for regulation of translation elongation via two different pathways.The amount of proteins synthesized in a
cell must be tuned in response to chang-
ing environmental and developmental
conditions. While regulation of gene
expression at the transcriptional level
has been described for decades, the
importance of translational control in
cellular responses has more recently
also been recognized, and an increasing
number of subtle mechanisms to regu-
late translation elongation have been
discovered.
Translation elongation factor 2 (EF2)
occupies an essential role in protein
translation, where it catalyzes the translo-
cation of the ribosome along the mRNA.
EF2 contains a diphtamide modificationon a conserved histidine residue, which
interacts with the ribosomal decoding
center (Schaffrath et al., 2014). In eukary-
otes, addition of this modification occurs
via a four-step pathway involving the pro-
teins Dph1–Dph7. The first step in this
pathway is catalyzed by the [4Fe-4S] clus-
ter-containing heterodimeric protein
complex Dph1/Dph2, with the help of
Dph3 and Dph4. Although the diphtamide
group of EF2 is the target for ADP-ribosy-
lation by the bacterial diphtheria toxin, its
exact physiological role is not yet fully un-
derstood. Recently, it has been sug-
gested that cells have an in-built capacity
to ADP-ribosylate the diphtamide group
and that this activity is increased undercertain cellular stresses, leading to a
global decrease of protein translation at
the expense of an upregulation of IRES-
dependent translation of mRNAs impli-
cated in oxidative stress protection
(Argu¨elles et al., 2014) (Figure 1).
Codon bias in certain subsets of
genes, coupled to regulation of specific
tRNA modifications, forms another strat-
egy to regulate translation elongation.
Chemical modifications at the wobble
position of tRNA play an important role
in translation rate and accuracy by
stabilizing codon-anticodon interactions
in the A site of the ribosome. Accord-
ingly, it has become increasingly
apparent recently that tRNA wobble15 ª2015 Elsevier Ltd All rights reserved 7
Figure 1. The Role of Kti11/Kti13 in Translation Elongation
Glatt et al. (2015) report the crystal structure of the Kti11/Kti13 complex and show that this protein complex is required for both elongator-mediated tRNA modi-
fication and diphtamidemodification of Ef2. These findings suggest that the Kti11/Kti13 complex forms a hub for modulating translation levels of specific mRNAs
via two different routes.
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Previewsmodifications provide cells with a power-
ful tool to regulate specific gene expres-
sion at the translational level (Begley
et al., 2007). This view also implies that
the tRNA modifications should be
dynamically altered in response to a
certain stimulus. An abundant modi-
fication found at the wobble uridine
of tRNA isoacceptors that decode A
and G ending codons in split codon
boxes is the 5-carbamoylmethyluridine
(ncm5U) or 5-methoxycarbonylmethyluri-
dine modification (mcm5U), or derivatives
thereof. Biosynthesis of this modification
involves the Elongator complex, a large
macromolecular complex that is built up
by two copies of each of its six subunits,
Elp1–6 (Glatt et al., 2012) (Figure 1). The
Elongator complex was initially identified
as an RNA polymerase II-associated
transcription elongation factor acting as
a histone acetylase, but over the years
it was linked to a multitude of cellular
functions including exocytosis, zygotic
paternal genome demethylation, acetyla-8 Structure 23, January 6, 2015 ª2015 Elsevition of a-tubulin, and acetylation of
Bruchpilot (Verse´es et al., 2010). How-
ever, lately, more and more evidence is
being accumulated that the most impor-
tant (but possibly not only) cellular func-
tion of Elongator is situated in tRNA
modification, where the main catalytic
steps seem to be performed by the
Elp3 subunit that consists out of a
GNAT domain and a [4Fe-4S]-containing
radical SAM domain. In a number of
recent studies it has been shown
that specific functional sets of genes,
involved in stress response and cell cycle
regulation are highly biased toward the
AAA or AGA codons for lysine and argi-
nine, respectively, thus rendering their
expression levels dependent upon the
Elongator-catalyzed mcm5(s2)U tRNA
modification (Begley et al., 2007; Bauer
et al., 2012). The level of mcm5U-modi-
fied tRNA is in turn under control of the
cell cycle and can be increased in
response to DNA damaging agents (Patil
et al., 2012). Apart from the six Elongatorer Ltd All rights reservedproteins, four more factors called Kti11,
Kti12, Kti13, and Kti14 were found to
be required for the mcm5U tRNA modifi-
cation through Elongator, where Kti11 is
identical to Dph3 involved in EF2 diphta-
mide modification. The exact functions of
these four proteins are still not fully
understood.
In this issue of Structure, Glatt et al.
(2015) provide evidence that Kti11 (or
Dph3) and Kti13 from yeast form a stable
1:1 complex in vitro, which is involved in
both tRNA modification via Elongator
and EF2 modification through interaction
with the Dph1/Dph2 complex. Crystal
structures of Kti13 and the Kti11/
Kti13 complex are presented, providing
detailed structural information on the
interaction mode of both proteins for
the first time (Figure 1). In agreement
with a recently published paper by
Dong et al. (2014), it was found that
Kti11, which was originally described as
a Zn2+-binding protein, can also bind
Fe2+ in vitro and in vivo via interaction
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Previewswith four conserved cysteine residues.
While mcm5U-modified tRNA is the target
of site-specific cleavage by the Kluyvero-
myces lactis killer toxin, diphtamidemodi-
fied EF2 is subjected to inactivation (via
ADP-ribosylation) by the diphtheria toxin.
Resistance to either of both toxins thus
allows an in vivo screening for the pres-
ence of the modifications. Using this
methodology Glatt et al. (2015) show
that mutations that disrupt the Kti11/
Kti13 interaction abolishes both tRNA
and EF2 modification, showing that both
proteins function in a concerted way.
While heterodimerization seems to be an
absolute requirement for in vivo activity
of Kti11/Kti13, it is not a sufficient condi-
tion for the modification reactions to
occur. Indeed nondisruptive mutations
can be identified that abolish both the
tRNA and EF2 modification reaction.
Interestingly, point mutations were also
identified that affected only one of the
two modification reactions, indicating
differences in the interaction and/or acti-
vation mode of Kti11/Kti13 with either
Elongator or Dph1/Dph2. Furthermore,
while binding of Fe2+ to Kti11 is not
required for interaction with Kti13, it is
absolutely required for the in vivo modifi-
cation of tRNA and EF2 in agreement
with its previously proposed role of elec-
tron donor to the [4Fe-4S] clusters of
Dph2 and Elp3 (Dong et al., 2014). A final
tantalizing observation concerns the
specific interaction of Kti13 with lipo-
somes containing the phosphoinositides
PI(4,5)P2 or PI(3,5)P2, while no such inter-
action is taking place with other signaling
lipids. This still largely unaddressed
observation points toward an incorpora-
tion of the Kti11/Kti13 complex in a larger
signaling cascade.
The results presented in this article shed
new light on the way the Kti11/Kti13 pro-
tein complex connects to two distinct
modification reactions: one tRNA modifi-
cation and one protein modification.
Despite these seemingly very differentmodifications, intriguing parallels can be
drawn. While the mcm5U modification is
present at the wobble position of the
tRNA anticodon loop, the diphtamide
modification is present in a region of EF2
that mimics the tRNA anticodon loop,
and both modifications are positioned in
the decoding center of the ribosome.
Furthermore, evidence has recently been
accumulating that both modifications are
implicated in the regulation of the expres-
sion levels of specific subclasses of pro-
teins mainly involved in stress responses.
As such, the Kti11/Kti13 complex seems
to be located at the nexus of two parallel
pathways affecting protein translation
elongation, making it potentially an ideal
target for regulation in response to
external signals. Although it still needs to
be investigated in more detail, the obser-
vation that Kti13 interacts specifically
with PI(4,5)P2 is highly compelling in this
regard. PI(4,5)P2 is a well-established
signaling lipid whose levels are often un-
der control of transmembrane receptors.
Such regulation by external cues would
be in agreement with a number of reports
concerning the direct regulation of Elon-
gator through receptor signaling. Indeed,
Elongator seems to be directly influenced
by phosphorylation of its subunits by an
interplay of the kinases Hrr25 (Kti14) and
Kti12 and the phosphatase Sit4. More-
over, in Drosophila, a direct interaction
has been shown to occur between Poly
(the homolog of Elp6) and the transmem-
brane insulin receptor (InR), therebymedi-
ating, via the conversion of PI(4,5)P2 to
PI(3,4,5)P3, the InR-mTOR pathway (Bo-
lukbasi et al., 2012). Also EF2 is under
direct control of phosphorylation by EF2
kinase, and, similarly, a regulation of the
latter by the InR-mTOR pathway has
been reported (Browne and Proud,
2004). Together, all these data hint toward
a central role of Kti11/Kti13 in the transla-
tional regulation of a number of stress-
related genes via two different pathways.
Further research is clearly required toStructure 23, January 6, 20obtain more detailed information on the
interaction of Kti11/Kti13 with either the
Elongator or Dph1/Dph2 complex. Further
characterization of the Kti13-PI(4,5)P2
interaction will moreover be necessary to
shed more light on the importance of this
finding in the frame of a general regulatory
pathway.
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